Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2021-04-13 Director's Dealing
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) and Korea Exchange. It details the share ownership and changes in holdings (specifically stock options exercised) by a director (Park Cheol-won) of the company 'KoBioLabs'. This type of filing is a standard disclosure for insider transactions and ownership changes, which falls under the 'Director's Dealing' category.
2021-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This document details the share ownership and changes in holdings (specifically stock options exercised) by a company executive (Nam Tae-wook of KoBioLabs). This type of filing is categorized as a Director's Dealing (DIRS) report, as it tracks insider transactions and ownership status.
2021-04-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including stock option exercises and donation agreements. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes.
2021-04-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) meeting (기업설명회). It specifies the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation slides themselves or a financial report, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' (RNS) category as it is a standard corporate disclosure of an IR event.
2021-04-07 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (고바이오랩) regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the impact on total shares, and the list of individuals (directors and employees) who exercised these options. This type of disclosure regarding capital changes and share issuance resulting from option exercises is classified as a 'Share Issue/Capital Change' announcement.
2021-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a company's Annual General Meeting (AGM), specifically detailing the approval of financial statements, director appointments, and remuneration limits. It follows the standard format for 'Declaration of Voting Results' filings in the Korean market (KIND system).
2021-03-31 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.